Benzinga | Jan 4, 2022 09:31AM EST

Wells Fargo Maintains Equal-Weight on Eli Lilly, Raises Price Target to $280

Wells Fargo analyst Mohit Bansal maintains Eli Lilly (NYSE:LLY) with a Equal-Weight and raises the price target from $270 to $280.